These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 27401651)

  • 21. Breast conserving therapy is associated with improved overall survival compared to mastectomy in early-stage, lymph node-negative breast cancer.
    Almahariq MF; Quinn TJ; Siddiqui Z; Jawad MS; Chen PY; Gustafson GS; Dilworth JT
    Radiother Oncol; 2020 Jan; 142():186-194. PubMed ID: 31615634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is biological subtype prognostic of locoregional recurrence risk in women with pT1-2N0 breast cancer treated with mastectomy?
    Truong PT; Sadek BT; Lesperance MF; Alexander CS; Shenouda M; Raad RA; Taghian AG
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):57-64. PubMed ID: 24161421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective comparison of outcome after treatment for triple-negative and non-triple-negative breast cancer.
    Joyce DP; Murphy D; Lowery AJ; Curran C; Barry K; Malone C; McLaughlin R; Kerin MJ
    Surgeon; 2017 Oct; 15(5):272-277. PubMed ID: 28277293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The influence of molecular classification of breast cancer on the safety of breast-conserving surgery].
    Li Y; Mu L; Ruan YX; Wang YT; Zhang D; Zhou H; Wang X
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):341-346. PubMed ID: 29860760
    [No Abstract]   [Full Text] [Related]  

  • 25. The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database.
    Chen QX; Wang XX; Lin PY; Zhang J; Li JJ; Song CG; Shao ZM
    Oncotarget; 2017 Jan; 8(3):4773-4780. PubMed ID: 27999201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiotherapy can improve the disease-free survival rate in triple-negative breast cancer patients with T1-T2 disease and one to three positive lymph nodes after mastectomy.
    Chen X; Yu X; Chen J; Yang Z; Shao Z; Zhang Z; Guo X; Feng Y
    Oncologist; 2013; 18(2):141-7. PubMed ID: 23335622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast conserving surgery (BCS) with adjuvant radiation therapy showed improved prognosis compared with mastectomy for early staged triple negative breast cancer patients Running title: BCS had better prognosis than mastectomy for early TNBC patients.
    Wang SE; Sun YD; Zhao SJ; Wei F; Yang G
    Math Biosci Eng; 2019 Sep; 17(1):92-104. PubMed ID: 31731341
    [No Abstract]   [Full Text] [Related]  

  • 28. Early-stage young breast cancer patients: impact of local treatment on survival.
    Bantema-Joppe EJ; de Munck L; Visser O; Willemse PH; Langendijk JA; Siesling S; Maduro JH
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e553-9. PubMed ID: 21601378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncologic safety of breast conserving surgery after tumour downsizing by neoadjuvant therapy: a retrospective single centre cohort study.
    Fitzal F; Riedl O; Mittlböck M; Dubsky P; Bartsch R; Steger G; Jakesz R; Gnant M
    Breast Cancer Res Treat; 2011 May; 127(1):121-8. PubMed ID: 20848185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of local surgical treatment on survival in young women with T1 breast cancer: long-term results of a population-based cohort.
    Jeon YW; Choi JE; Park HK; Kim KS; Lee JY; Suh YJ
    Breast Cancer Res Treat; 2013 Apr; 138(2):475-84. PubMed ID: 23456232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome following local-regional recurrence in women with early-stage breast cancer: impact of biologic subtype.
    Braunstein LZ; Niemierko A; Shenouda MN; Truong L; Sadek BT; Abi Raad R; Wong JS; Punglia RS; Taghian AG; Bellon JR
    Breast J; 2015; 21(2):161-7. PubMed ID: 25559656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients.
    Urru SAM; Gallus S; Bosetti C; Moi T; Medda R; Sollai E; Murgia A; Sanges F; Pira G; Manca A; Palmas D; Floris M; Asunis AM; Atzori F; Carru C; D'Incalci M; Ghiani M; Marras V; Onnis D; Santona MC; Sarobba G; Valle E; Canu L; Cossu S; Bulfone A; Rocca PC; De Miglio MR; Orrù S
    BMC Cancer; 2018 Jan; 18(1):56. PubMed ID: 29310602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcome of isolated locoregional recurrence in patients with breast cancer according to their primary local treatment.
    Shenouda MN; Sadek BT; Goldberg SI; Keruakous AR; Croft BJ; Abi Raad RF; Taghian AG
    Clin Breast Cancer; 2014 Jun; 14(3):198-204. PubMed ID: 24485702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Survival After Breast-Conserving Therapy vs Mastectomy Among Patients With or Without the BRCA1/2 Variant in a Large Series of Unselected Chinese Patients With Breast Cancer.
    Wan Q; Su L; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
    JAMA Netw Open; 2021 Apr; 4(4):e216259. PubMed ID: 33890992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy.
    Yagata H; Kajiura Y; Yamauchi H
    Breast Cancer; 2011 Jul; 18(3):165-73. PubMed ID: 21290263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognosis following local recurrence after breast conserving treatment in young women with early breast cancer.
    van der Sangen MJ; Poortmans PM; Scheepers SW; Lemaire BM; van Berlo CL; Tjan-Heijnen VC; Voogd AC
    Eur J Surg Oncol; 2013 Aug; 39(8):892-8. PubMed ID: 23726902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Adjuvant Treatments for T1 N0 M0 Triple-Negative Breast Cancer.
    Zhai Z; Zheng Y; Yao J; Liu Y; Ruan J; Deng Y; Zhou L; Zhao P; Yang S; Hu J; We B; Wu Y; Zhang D; Kang H; Dai Z
    JAMA Netw Open; 2020 Nov; 3(11):e2021881. PubMed ID: 33211105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Time from Completion of Neoadjuvant Chemotherapy to Surgery on Survival Outcomes in Breast Cancer Patients.
    Sanford RA; Lei X; Barcenas CH; Mittendorf EA; Caudle AS; Valero V; Tripathy D; Giordano SH; Chavez-MacGregor M
    Ann Surg Oncol; 2016 May; 23(5):1515-21. PubMed ID: 26678405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving local control with breast-conserving therapy: a 27-year single-institution experience.
    Cabioglu N; Hunt KK; Buchholz TA; Mirza N; Singletary SE; Kuerer HM; Babiera GV; Ames FC; Sahin AA; Meric-Bernstam F
    Cancer; 2005 Jul; 104(1):20-9. PubMed ID: 15912514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast-conserving surgery vs. total mastectomy in patients with triple negative breast cancer in early stages: A propensity score analysis.
    De-la-Cruz-Ku G; Valcarcel B; Morante Z; Möller MG; Lizandro S; Rebaza LP; Enriquez D; Luque R; Luján-Peche MG; Eyzaguirre-Sandoval ME; Saavedra A; Razuri C; Pinto JA; Fuentes HA; Neciosup SP; Gomez HL
    Breast Dis; 2020; 39(1):29-35. PubMed ID: 31903977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.